LB Pharmaceuticals Inc Common Stock (NASDAQ: LBRX) last traded at $35.37, down 1.57% on the session. The quote above updates while this page is open; the figures below are drawn from LB Pharmaceuticals Inc Common Stock’s own filings and are restated only when a new one is published.
LB Pharmaceuticals Inc Common Stock trades on NASDAQ under the ticker LBRX. Its market capitalisation is $1.14 billion.
Valuation measures for LB Pharmaceuticals Inc Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.14B |
|---|---|
| Enterprise value | $887.08M |
| Price / book | 3.43 |
| Beta | 0.54 |
Trailing-twelve-month figures tagged in LB Pharmaceuticals Inc Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$85.69M |
| Return on equity | -25.78% |
|---|
| Cash | $283.11M |
|---|
Range and volume for LBRX over the past 52 weeks.
| 52-week high | $50.16 |
|---|---|
| 52-week low | $14.32 |
| Volume | 48.9K |
| Average volume | 349.0K |
| Previous close | $35.93 |
Invest a chosen dollar amount in LB Pharmaceuticals Inc Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell LBRX.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.